re: Ann: MSB to Apply for Regulatory Approval...
from the announcement:
"Mesoblast successfully completed an Australian clinical trial of its proprietary autologous stem cell therapy for the repair of non-healing long bone fractures of the legs. The bone repair product for this trial was manufactured by Cell Therapies."
so, it's only the higher cost autologous, for non repairing fractures, but a very important first step. Might bring in a bit of revenue while the allogeneic cells are still being trialled. Im not sure how long the approval takes from TGA.
re: Ann: MSB to Apply for Regulatory Approval... from the...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |